1. 1. Aspinall E, Hawkins G, Fraser A, Hutchinson S, Goldberg D. Hepatitis B prevention, diagnosis, treatment and care: a review. Occupational medicine. 2011;61(8):531-40. 2. Salisbury D, Ramsay M, Noakes K. Immunisation against infectious diseases: The Stationery Office
2. 2006. 3. Kao J-H. Diagnosis of hepatitis B virus infection through serological and virological markers. Expert review of gastroenterology and hepatology. 2008;2(4):553-62. 4. Raimondo G, Pollicino T, Squadrito G. Clinical virology of hepatitis B virus infection. Journal of hepatology. 2003;39:26-30. 5. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. Journal of hepatology. 2003;39:64-9. 6. Fattovich G. Natural history of hepatitis B. Journal of hepatology. 2003;39:50-8. 7. Hajarizadeh B, Mesgarpour B, Nasiri MJ, Alavian SM, Merat S, Poustchi H, et al. Estimating the prevalence of hepatitis B virus infection and exposure among general population in Iran. Hepatitis Monthly. 2017;17(8). 8. Poustchi H, MOHAMMADNEZHAD M, Malekzadeh R. Hepatitis B virus infection in Iran. 2007. 9. Alavian SM. Hepatitis B virus infection in Iran
3. Changing the epidemiology. 2010. 10. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2009;14(4):249. 11. Hajikazemi E. Hepatitis B vaccination. Iran Journal of Nursing. 2001;13(25):58-63. 12. Rezaee R, Aghcheli B, Poortahmasebi V, Qorbani M, Alavian SM, Jazayeri SM. Prevalence of national responsiveness to HBV vaccine after 22 years of Iranian expanded program on immunization (EPI): a systematic review and meta-analysis study. Hepatitis monthly. 2015;15(5). 13. Norouzirad R, Shakurnia AH, Assarehzadegan M-A, Serajian A, Khabazkhoob M. Serum levels of anti-hepatitis B surface antibody among vaccinated population aged 1 to 18 years in ahvaz city southwest of iran. Hepatitis monthly. 2014;14(1). 14. Chang M-H, You S-L, Chen C-J, Liu C-J, Lai M-W, Wu T-C, et al. Long-term effects of hepatitis B immunization of infants in preventing liver cancer. Gastroenterology. 2016;151(3):472-80. e1. 15. Nilforushan M. EXPANDED PROGRAMME ON IMMUNIZATION AND HEPATITIS B VACCINE. Razi Journal of Medical Sciences. 1994;1:44-9. 16. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine. 2003;21(7-8):685-91. 17. Amin S, Andalibi S, Mahmoudi M. Anti-HBs response and its protective effect in children and adults receiving hepatitis B recombinant vaccine in Tehran. 2002. 18. Zad Fattah F, Blourian M, Sadegh A . The evaluation of Hepatitis B Antibody titer among vaccinated students in Ardebil College of Dentistry. Iranian Journal of Medical Microbiology2016;10(3): 68-72. 19. Tashakkori F, Yahyapour Y, Abdollahpour SM, Dargahi S, Bagheri M, Haji-Ahmadi M. Serological markers of hepatitis B in Students at Babol University of Medical Sciences. Iranian Journal of Medical Microbiology. 2016;9(4):79-86. 20. Lee KH, Shim KS, Lim IS, Chae SA, Yun SW, Lee NM, et al. Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea. BMC pediatrics. 2017;17(1):164. 21. Namdari S, Arabsolghar R, Sharifzadeh S, Farhadi A, Toopchi S, Seyyedi N, et al. Anti-HBs Antibody Levels and Anti-HBc Detection Among HBV-Vaccinated Freshmen Enrolled in the Department of Laboratory Sciences, Shiraz University of Medical Sciences, Iran. Shiraz E-Medical Journal. 2018;19(7). 22. Arefkhah N, Vafazadeh S, Shahriarirad S, Ghorbani F, Zoghi S, Emami M, et al. Serum levels of anti-hepatitis B surface antibodies among vaccinated children aged 1 to 12 years in a rural community in Fars Province, southern Iran. Journal of Immunoassay and Immunochemistry. 2019:1-8. 23. Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World journal of hepatology. 2015;7(24):2503. 24. Nejad HN, Ghorbani G, Razaghi R, Akbari H. Comparison of Two Recombinant Hepatitis B Vaccines. Hepatitis Monthly. 2009;9(3). 25. Roberts S. DNA tumour viruses: virology, pathogenesis and vaccines: Caister Academic Press
4. 2018. 26. Cooper C, Mackie D. Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy. Expert review of vaccines. 2011;10(4):417-27. 27. Fabrizi F, Dixit V, Martin P. Meta‐analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end‐stage renal disease. Alimentary pharmacology and therapeutics. 2006;23(11):1559-66.
5. Hepatitis B prevention, diagnosis, treatment and care: a review